Ivermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in Healthcare Workers: A Propensity Score-Matched Retrospective Cohort Study

Overview of attention for article published in Cureus, August 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#12 of 26,132)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 6 news outlets
blogs: 3 blogs

twitter: 3248 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 63 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 3 posts from 3 blogs.

Reduced Risk of SARS CV2 Infection: IVM vs. VAX

Climate Science, 08 May 2022

A year ago, it was already evident that Ivermectin provided superior protection against SARS CV2 infection compared to Pfizer…

Reduced Risk of SARS CV2 Infection: IVM vs. VAX

Iowa Climate, 07 May 2022

A year ago it was already evident that Ivermectin provided superior protection against SARS CV2 infection compared to Pfizer…

Reduced Risk of SARS CV2 Infection: IVM vs. VAX

Science Matters Blog, 07 May 2022

A year ago it was already evident that Ivermectin provided superior protection against SARS CV2 infection compared to Pfizer…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.